First-in-Human (FIH) Study on the Feasibility and Safety of the TaviPilot Augmented Reality Guidance Software

NANot yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

May 30, 2026

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

TAVR using a guidance software

TAVR procedure with TAVIPILOT augmented reality guidance software operating in parallel on a separate screen in a blind setup, enabling clinicians to assess the analysis and recommendations provided by the software, either immediately after valve deployment or following the completion of the procedure.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Caranx Medical

INDUSTRY

NCT07043075 - First-in-Human (FIH) Study on the Feasibility and Safety of the TaviPilot Augmented Reality Guidance Software | Biotech Hunter | Biotech Hunter